Title of article
Anticoagulation in Lower Risk Atrial Fibrillation: A two Edged Sword
Author/Authors
Kiani, Reza tehran university of medical sciences tums - Rajaie Cardiovascular Medical and Research Center - Cardiovascular Intervention Research Center, تهران, ايران
From page
74
To page
75
Abstract
Dear Editor, Inside the previous issue of Research in Cardiovascu- lar Medicine, Arya et-al presented a nice review of novel anticoagulation strategies in patients with non-valvular atrial fibrillation (1). Through this recent review and the upcoming guidelines from various medical societies, it is plausible that the decades-long reign of coumadin in primary and secondary prevention of systemic thrombo- embolism in atrial fibrillation (AF) will soon come to an end. However, what is less clear out of these recent devel- opments might be this question: How should I treat my AF patient with a lower risk of embolic events?
Keywords
Atrial Fibrillation , Anticoagulant Drugs , Antiplatelet Drugs
Journal title
Research in Cardiovascular Medicine
Journal title
Research in Cardiovascular Medicine
Record number
2557466
Link To Document